Bupropion Hydrochloride
- Product NDC
- 68788-7121
- 11-digit product format
- 687887121
- Labeler code
- 68788
- Product ID
- 68788-7121_60f4ad0f-8564-4f33-bfe3-5ad817e492bb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals, Inc.
- Application
- ANDA090693
- Marketing category
- ANDA
- Marketing start
- 2018-03-22
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7121-1 | 68788712101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7121-1) | 2018-03-22 | 0000-00-00 | No | No | Current |
| 68788-7121-3 | 68788712103 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7121-3) | 2018-03-22 | 0000-00-00 | No | No | Current |
| 68788-7121-6 | 68788712106 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7121-6) | 2018-03-22 | 0000-00-00 | No | No | Current |
| 68788-7121-8 | 68788712108 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7121-8) | 2018-03-22 | 0000-00-00 | No | No | Current |
| 68788-7121-9 | 68788712109 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7121-9) | 2018-03-22 | 0000-00-00 | No | No | Current |